Eupraxia Pharmaceuticals EPRX Balance Sheet (2022-2026)

NASDAQ EPRX
$8.31 +0.10 (+1.16%)
At close: Sep 29, 2026 · 4:00 PM EDT
Reported Financials

Eupraxia Pharmaceuticals Quarterly Balance Sheet

Periods 12 quarters
Latest Jun 2026

Eupraxia Pharmaceuticals reported total assets of $139.91M and total liabilities of $10.23M for the quarter ended Jun 2026, up 492.9% year over year. This balance sheet covers 12 quarters of results from Dec 2022 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet Dec2022 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Accumulated Depreciation 0.29M0.40M
Receivables - AccuredAcc. Int. Receivables -0.00M-1.24M
Assets
Current Assets
Cash & EquivalentsCash & Equiv. 18.26M19.34M35.91M23.32M8.66M33.10M27.45M19.77M88.96M80.56M58.50M52.43M
Receivables - NetNet Receivables 0.15M0.26M0.72M
Receivables - OtherOther Receivables 0.09M0.19M0.17M0.16M0.11M0.23M0.24M0.13M0.14M0.67M0.66M0.69M
Receivables 0.34M0.49M1.39M
Prepaid Assets 0.24M0.27M0.14M0.00M1.11M0.91M2.93M2.30M3.86M2.58M2.46M
Current Assets 18.59M19.80M36.22M24.53M9.89M34.44M28.61M22.83M91.40M85.10M142.13M136.80M
Non-Current Assets
Property, Plant & Equipment (Net) 0.44M0.41M0.38M0.35M0.37M0.36M0.50M0.66M0.68M0.83M1.16M1.21M
Other Non-Current Assets 0.00M0.01M0.01M1.05M1.12M0.08M0.08M0.08M0.10M0.06M0.06M0.05M
Non-Current Assets 0.53M0.46M0.42M0.45M0.47M0.51M0.63M0.77M0.95M1.05M3.23M3.10M
Assets 19.12M20.27M36.64M24.98M10.36M34.94M29.23M23.60M92.35M86.15M145.35M139.91M
Liabilities
Current Liabilities
Accounts Payables 2.93M3.92M3.97M1.98M2.29M3.03M2.15M2.58M3.73M5.55M7.16M8.39M
Payables 2.93M3.92M3.97M1.98M2.29M3.03M2.15M2.58M3.73M5.55M7.16M8.39M
Other Accumulated Expenses 0.16M
Short term Debt 0.08M
Current Leases 0.05M0.05M0.03M0.01M0.07M0.05M0.04M0.08M0.08M0.20M0.16M
Current Taxes 8.74M
Total Current Liabilities 3.06M19.37M18.53M11.60M2.37M3.10M2.20M2.62M3.81M5.63M7.36M8.55M
Non-Current Liabilities
Non-Current Debt 0.06M0.06M0.04M0.02M
Convertible Debt 8.74M10.34M9.48M4.53M-0.36M
Minority Interest -0.58M-1.32M-1.44M-1.49M-1.54M-1.57M-1.57M-1.58M-1.59M-1.60M-1.60M-1.60M
Operating Leases 0.05M0.05M0.04M0.07M0.08M0.09M0.08M1.80M1.68M
Total Liabilities 11.91M19.37M18.53M11.64M2.39M3.10M2.20M2.62M3.91M5.70M9.17M10.23M
Shareholder's Equity
Total Debt 0.14M0.06M0.04M0.02M
Common Equity 7.21M0.89M18.11M13.34M7.98M31.84M27.03M20.98M88.44M80.45M136.19M129.67M
Liabilities and Shareholders Equity 19.12M20.27M36.64M24.98M10.36M34.94M29.23M23.60M92.35M86.15M145.35M139.91M
Retained Earnings -77.28M-105.50M-111.54M-117.55M-123.49M-131.00M-146.51M-152.87M-169.58M-182.23M-196.72M
Preferred Shares 31.71M31.71M29.74M

Eupraxia Pharmaceuticals Balance Sheet API

Pull Eupraxia Pharmaceuticals's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=EPRX&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY